Literature DB >> 2458911

Antigenic features of human follicle stimulating hormone delineated by monoclonal antibodies and construction of an immunoradiomometric assay.

P Berger1, W Panmoung, D Khaschabi, B Mayregger, G Wick.   

Abstract

The characterization of human (h) FSH with 181 monoclonal antibodies (MCA) allowed the elucidation of its antigenic topography. One- and two-site, limited as well as excess reagent type radioimmuno- and enzymoimmunoassays revealed three main categories of MCA molecular binding specificities; two thirds of all antibodies were directed against the alpha-subunit and one fourth toward the beta-chain, and less than one tenth recognized the conformationally (c) intact holohormone. With high frequency immunization schedules these specificities were shifted toward a higher proportion of beta-MCA. On the basis of intra- and interspecies cross-reaction studies as well as epitope contiguity analyses by sandwich assays, the three main categories could be further subdivided into nine epitopes: 1) five epitopes associated with the alpha-subunit, two of which were suprisingly shared by other species, and two being iodination sensitive, 2) two evolutionary conserved structures on the beta-subunit, adjacent to each other, and 3) two c-determinants, one of these present also on hTSH. The epitopes were arranged in three major antigenic domains, which seems to be a common homologous construction principle of the four human glycoprotein hormones: a central domain, consisting of three identically arranged alpha- and similarly located c-epitopes, is flanked by a single spatially distinct domain on each subunit. The establishment of an epitope map was followed by the construction of an immunoradiometric assay with a sensitivity of 0.25 ng hFSH/ml and an apparent cross-reactivity vs. hLH, hTSH, and hCG of less than 1%.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458911     DOI: 10.1210/endo-123-5-2351

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Molecular structures of glycoprotein hormones and functions of their carbohydrate components.

Authors:  A Stockell Hartree; A G Renwick
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

2.  Mapping of a discontinuous and highly conformational binding site on follicle stimulating hormone subunit-beta (FSH-beta) using domain Scan and Matrix Scan technology.

Authors:  Peter Timmerman; Evert Van Dijk; Wouter Puijk; Wim Schaaper; Jerry Slootstra; Stephen J Carlisle; John Coley; Steve Eida; M Gani; Tim Hunt; Paul Perry; Gerry Piron; Rob H Meloen
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

3.  Enhancement in antigen binding by a combination of synergy and antibody capture.

Authors:  T Klonisch; G Panayotou; P Edwards; A M Jackson; P Berger; P J Delves; T Lund; I M Roitt
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

4.  Decreased levels of genuine large free hCG alpha in men presenting with abnormal semen analysis.

Authors:  Christoph Zenzmaier; Regine Gerth; Matthias Gruschwitz; Herbert Lindner; Eugen Plas; Peter Berger
Journal:  Reprod Biol Endocrinol       Date:  2011-08-12       Impact factor: 5.211

5.  Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients.

Authors:  Christoph Zenzmaier; Martin Heitz; Helmut Klocker; Marion Buck; Robert A Gardiner; Peter Berger
Journal:  J Transl Med       Date:  2011-11-10       Impact factor: 5.531

6.  Validation of 125I-hCG as a marker for elimination of hCG and stability of 125I-hCG after in vivo injection in humans.

Authors:  T B Christensen; J Marqversen; F Engbaek; P Berger; T Bacher; H von der Maase
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

7.  Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop.

Authors:  P Berger; E Paus; P M Hemken; C Sturgeon; W W Stewart; J P Skinner; L C Harwick; S C Saldana; C S Ramsay; K R Rupprecht; K H Olsen; J-M Bidart; U-H Stenman
Journal:  Tumour Biol       Date:  2013-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.